OBJECTIVES: The aim of this study was to assess if genetic variation in the PACE4 (paired amino acid converting enzyme 4) gene Pcsk6 influences the risk for symptomatic knee osteoarthritis (OA). METHODS: Ten PCSK6 single nucleotide polymorphisms were tested for association in a discovery cohort of radiographic knee OA (n=156 asymptomatic and 600 symptomatic cases). Meta-analysis of the minor allele at rs900414 was performed in three additional independent cohorts (total n=674 asymptomatic and 2068 symptomatic). Pcsk6 knockout mice and wild-type C57BL/6 mice were compared in a battery of algesiometric assays, including hypersensitivity in response to intraplantar substance P, pain behaviours in response to intrathecal substance P and pain behaviour in the abdominal constriction test. RESULTS: In the discovery cohort of radiographic knee OA, an intronic single nucleotide polymorphism at rs900414 was significantly associated with symptomatic OA. Replication in three additional cohorts confirmed that the minor allele at rs900414 was consistently increased among asymptomatic compared to symptomatic radiographic knee OA cases in all four cohorts. A fixed-effects meta-analysis yielded an OR=1.35 (95% CI 1.17 to 1.56; p=4.3×10(-5) and no significant between-study heterogeneity). Studies in mice revealed that Pcsk6 knockout mice were significantly protected against pain in a battery of algesiometric assays. CONCLUSIONS: These results suggest that a variant in PCSK6 is strongly associated with protection against pain in knee OA, offering some insight as to why, in the presence of the same structural damage, some individuals develop chronic pain and others are protected. Studies in Pcsk6 null mutant mice further implicate PACE4 in pain.
OBJECTIVES: The aim of this study was to assess if genetic variation in the PACE4 (paired amino acid converting enzyme 4) gene Pcsk6 influences the risk for symptomatic knee osteoarthritis (OA). METHODS: Ten PCSK6 single nucleotide polymorphisms were tested for association in a discovery cohort of radiographic knee OA (n=156 asymptomatic and 600 symptomatic cases). Meta-analysis of the minor allele at rs900414 was performed in three additional independent cohorts (total n=674 asymptomatic and 2068 symptomatic). Pcsk6 knockout mice and wild-type C57BL/6 mice were compared in a battery of algesiometric assays, including hypersensitivity in response to intraplantar substance P, pain behaviours in response to intrathecal substance P and pain behaviour in the abdominal constriction test. RESULTS: In the discovery cohort of radiographic knee OA, an intronic single nucleotide polymorphism at rs900414 was significantly associated with symptomatic OA. Replication in three additional cohorts confirmed that the minor allele at rs900414 was consistently increased among asymptomatic compared to symptomatic radiographic knee OA cases in all four cohorts. A fixed-effects meta-analysis yielded an OR=1.35 (95% CI 1.17 to 1.56; p=4.3×10(-5) and no significant between-study heterogeneity). Studies in mice revealed that Pcsk6 knockout mice were significantly protected against pain in a battery of algesiometric assays. CONCLUSIONS: These results suggest that a variant in PCSK6 is strongly associated with protection against pain in knee OA, offering some insight as to why, in the presence of the same structural damage, some individuals develop chronic pain and others are protected. Studies in Pcsk6 null mutant mice further implicate PACE4 in pain.
Authors: Dale J Langford; Sara E Crager; Zarrar Shehzad; Shad B Smith; Susana G Sotocinal; Jeremy S Levenstadt; Mona Lisa Chanda; Daniel J Levitin; Jeffrey S Mogil Journal: Science Date: 2006-06-30 Impact factor: 47.728
Authors: Micky D Tortorella; Elizabeth C Arner; Robert Hills; Jennifer Gormley; Kam Fok; Lyle Pegg; Grace Munie; Anne-Marie Malfait Journal: Arch Biochem Biophys Date: 2005-10-26 Impact factor: 4.013
Authors: Anne-Marie Malfait; Elizabeth C Arner; Ruo-Hua Song; James T Alston; Stella Markosyan; Nicholas Staten; Zhiyong Yang; David W Griggs; Micky D Tortorella Journal: Arch Biochem Biophys Date: 2008-07-19 Impact factor: 4.013
Authors: Reva C Lawrence; David T Felson; Charles G Helmick; Lesley M Arnold; Hyon Choi; Richard A Deyo; Sherine Gabriel; Rosemarie Hirsch; Marc C Hochberg; Gene G Hunder; Joanne M Jordan; Jeffrey N Katz; Hilal Maradit Kremers; Frederick Wolfe Journal: Arthritis Rheum Date: 2008-01
Authors: Luda Diatchenko; Andrea G Nackley; Inna E Tchivileva; Svetlana A Shabalina; William Maixner Journal: Trends Genet Date: 2007-11-26 Impact factor: 11.639
Authors: Colleen R McNamara; Josh Mandel-Brehm; Diana M Bautista; Jan Siemens; Kari L Deranian; Michael Zhao; Neil J Hayward; Jayhong A Chong; David Julius; Magdalene M Moran; Christopher M Fanger Journal: Proc Natl Acad Sci U S A Date: 2007-08-08 Impact factor: 11.205
Authors: T Neogi; A Soni; S A Doherty; L L Laslett; R A Maciewicz; D J Hart; W Zhang; K R Muir; M Wheeler; C Cooper; T D Spector; F Cicuttini; G Jones; M Nevitt; Y Liu; N K Arden; M Doherty; A M Valdes Journal: Ann Rheum Dis Date: 2013-07-13 Impact factor: 19.103
Authors: Mukundan Attur; Svetlana Krasnokutsky; Alexander Statnikov; Jonathan Samuels; Zhiguo Li; Olga Friese; Marie-Pierre Hellio Le Graverand-Gastineau; Leon Rybak; Virginia B Kraus; Joanne M Jordan; Constantin F Aliferis; Steven B Abramson Journal: Arthritis Rheumatol Date: 2015-11 Impact factor: 10.995